Back

Efficacy of lipid lowering therapy beyond statins to prevent cardiovascular events: A meta-analysis

3 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Challenges in contemporary management of coronary artery disease Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Iryna Dykun

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

6 More presentations in this session

Presentation thumbnail
Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
Professor G. Ducrocq (Paris, FR)
Abstract Slides
Presentation thumbnail
The major bleeding event is the stronger predictor of long term mortality rather than the coronary event in the secondary prevention of ischemic heart disease in Japan
Doctor S. KAGEYAMA (Shizuoka, JP)
Abstract Slides
Presentation thumbnail
Impact of guideline-recommended medical therapy at discharge on long-term mortality in patients with or without left ventricular dysfunction after primary PCI for STEMI
Doctor D. Milasinovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Ten-year trends and outcomes in cardiogenic shock related to first-time acute myocardial infarction: a nationwide population-based cohort study.
Miss M. Dam Lauridsen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Trends in hospitalised cardiac arrest outcomes over 25 years in Scotland
Doctor R. Bing (Edinburgh, GB)
Abstract Slides

Access the full session

Session thumbnail
Challenges in contemporary management of coronary artery disease

The Event

Event poster

ESC Congress 2019

3 September 2019 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources